Shanthi Sivendran

Dissection of Immune Gene Networks in Primary Melanoma Tumors Critical for Antitumor Surveillance of Patients with Stage II–III Resectable Disease

Shanthi Sivendran, Rui Chang, Lisa Pham et al. · Journal of Investigative Dermatology · 2014 · 67 citations · Full text

Tumor Immunology, Cancer Immunosurveillance, Medicine +10

Illness Understanding of Oncology Patients in a Community-Based Cancer Institute

Shanthi Sivendran, Sarah M. Jenkins, Sarah Svetec et al. · Journal of Oncology Practice · 2017 · 20 citations · Full text

Defining the role of CD2 in disease progression and overall survival among patients with completely resected stage-II to -III cutaneous melanoma

Sara Harcharik, Sebastian Bernardo, Michael Pan et al. · Journal of the American Academy of Dermatology · 2014 · 17 citations

Surgical Oncology, Disease Progression, Medicine +10

Ring chromosome 18 abnormality in acute myelogenous leukemia: the clinical dilemma

Shanthi Sivendran, Stephen Gruenstein, Adriana K. Malone et al. · Journal of Hematology & Oncology · 2010 · 15 citations · Full text

Adverse event reporting in oncology clinical trials - lost in translation?

Shanthi Sivendran, Matthew D. Galsky · Expert Opinion on Drug Safety · 2016 · 15 citations · Full text

Clinical Endpoint, Adverse Drug Reaction, Translational Medicine +22